Royal Bank of Canada’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.34M | Sell |
|
|||||
|
2023
Q3 | $2.63M | Buy |
|
|||||
|
2023
Q2 | $1.71M | Sell |
|
|||||
|
2023
Q1 | $1.85M | Buy |
|
|||||
|
2022
Q4 | $1.42M | Buy |
|
|||||
|
2022
Q3 | $1.85M | Buy |
|
|||||
|
2022
Q2 | $1.63M | Buy |
|
|||||
|
2022
Q1 | $1.1M | Sell |
|
|||||
|
2021
Q4 | $8.62M | Buy |
|
|||||
|
2021
Q3 | $1.66M | Sell |
|
|||||
|
2021
Q2 | $3.56M | Sell |
|
|||||
|
2021
Q1 | $7.75M | Buy |
|
|||||
|
2020
Q4 | $7.45M | Buy |
|
|||||
|
2020
Q3 | $5.48M | Sell |
|
|||||
|
2020
Q2 | $5.02M | Buy |
|
|||||
|
2020
Q1 | $3.03M | Buy |
|
|||||
|
2019
Q4 | $698K | Buy |
|
|||||
|
2019
Q3 | $289K | Buy |
|
|||||
|
2019
Q2 | $373K | Sell |
|
|||||
|
2019
Q1 | $351K | Buy |
|
|||||
|
2018
Q4 | $199K | Sell |
|
|||||
|
2018
Q3 | $259K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $0 | Sell |
|
|||||
|
2017
Q1 | $3K | Sell |
|
|||||
|
2016
Q4 | $4K | Sell |
|
|||||
|
2016
Q3 | $17K | Sell |
|
|||||
|
2016
Q2 | $29K | Sell |
|
|||||
|
2016
Q1 | $412K | Buy |
|
|||||
|
2015
Q4 | $487K | Buy |
|
|||||
|
2015
Q3 | $404K | Sell |
|
|||||
|
2015
Q2 | $563K | Buy |
|
|||||
|
2015
Q1 | $520K | Buy |
|
|||||
|
2014
Q4 | $321K | Buy |
|
|||||
|
2014
Q3 | $167K | Buy |
|
|||||
|
2014
Q2 | $180K | Sell |
|
|||||
|
2014
Q1 | $189K | Sell |
|
|||||
|
2013
Q4 | $411K | Buy |
|
|||||
|
2013
Q3 | $356K | Buy |
|